1 Report Business Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Influenza (Flu) Antiviral Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 1.2.2 Penetration and Dehulling Inhibitors 1.2.3 DNA Polymerase Inhibitors 1.2.4 Reverse Transcriptase Inhibitors 1.2.5 Protein Inhibitors 1.2.6 Neuraminidase Inhibitors 1.2.7 Broad-spectrum Antiviral Drugs 1.3 Market by Application 1.3.1 Global Influenza (Flu) Antiviral Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 1.3.2 Hospital 1.3.3 Clinic 1.3.4 Household 1.3.5 Others 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Influenza (Flu) Antiviral Drugs Market Perspective (2017-2028) 2.2 Influenza (Flu) Antiviral Drugs Growth Trends by Region 2.2.1 Influenza (Flu) Antiviral Drugs Market Size by Region: 2017 VS 2021 VS 2028 2.2.2 Influenza (Flu) Antiviral Drugs Historic Market Size by Region (2017-2022) 2.2.3 Influenza (Flu) Antiviral Drugs Forecasted Market Size by Region (2023-2028) 2.3 Influenza (Flu) Antiviral Drugs Market Dynamics 2.3.1 Influenza (Flu) Antiviral Drugs Industry Trends 2.3.2 Influenza (Flu) Antiviral Drugs Market Drivers 2.3.3 Influenza (Flu) Antiviral Drugs Market Challenges 2.3.4 Influenza (Flu) Antiviral Drugs Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Influenza (Flu) Antiviral Drugs Players by Revenue 3.1.1 Global Top Influenza (Flu) Antiviral Drugs Players by Revenue (2017-2022) 3.1.2 Global Influenza (Flu) Antiviral Drugs Revenue Market Share by Players (2017-2022) 3.2 Global Influenza (Flu) Antiviral Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.3 Players Covered: Ranking by Influenza (Flu) Antiviral Drugs Revenue 3.4 Global Influenza (Flu) Antiviral Drugs Market Concentration Ratio 3.4.1 Global Influenza (Flu) Antiviral Drugs Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Influenza (Flu) Antiviral Drugs Revenue in 2021 3.5 Influenza (Flu) Antiviral Drugs Key Players Head office and Area Served 3.6 Key Players Influenza (Flu) Antiviral Drugs Product Solution and Service 3.7 Date of Enter into Influenza (Flu) Antiviral Drugs Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Influenza (Flu) Antiviral Drugs Breakdown Data by Type 4.1 Global Influenza (Flu) Antiviral Drugs Historic Market Size by Type (2017-2022) 4.2 Global Influenza (Flu) Antiviral Drugs Forecasted Market Size by Type (2023-2028) 5 Influenza (Flu) Antiviral Drugs Breakdown Data by Application 5.1 Global Influenza (Flu) Antiviral Drugs Historic Market Size by Application (2017-2022) 5.2 Global Influenza (Flu) Antiviral Drugs Forecasted Market Size by Application (2023-2028) 6 North America 6.1 North America Influenza (Flu) Antiviral Drugs Market Size (2017-2028) 6.2 North America Influenza (Flu) Antiviral Drugs Market Size by Type 6.2.1 North America Influenza (Flu) Antiviral Drugs Market Size by Type (2017-2022) 6.2.2 North America Influenza (Flu) Antiviral Drugs Market Size by Type (2023-2028) 6.2.3 North America Influenza (Flu) Antiviral Drugs Market Share by Type (2017-2028) 6.3 North America Influenza (Flu) Antiviral Drugs Market Size by Application 6.3.1 North America Influenza (Flu) Antiviral Drugs Market Size by Application (2017-2022) 6.3.2 North America Influenza (Flu) Antiviral Drugs Market Size by Application (2023-2028) 6.3.3 North America Influenza (Flu) Antiviral Drugs Market Share by Application (2017-2028) 6.4 North America Influenza (Flu) Antiviral Drugs Market Size by Country 6.4.1 North America Influenza (Flu) Antiviral Drugs Market Size by Country (2017-2022) 6.4.2 North America Influenza (Flu) Antiviral Drugs Market Size by Country (2023-2028) 6.4.3 U.S. 6.4.4 Canada 7 Europe 7.1 Europe Influenza (Flu) Antiviral Drugs Market Size (2017-2028) 7.2 Europe Influenza (Flu) Antiviral Drugs Market Size by Type 7.2.1 Europe Influenza (Flu) Antiviral Drugs Market Size by Type (2017-2022) 7.2.2 Europe Influenza (Flu) Antiviral Drugs Market Size by Type (2023-2028) 7.2.3 Europe Influenza (Flu) Antiviral Drugs Market Share by Type (2017-2028) 7.3 Europe Influenza (Flu) Antiviral Drugs Market Size by Application 7.3.1 Europe Influenza (Flu) Antiviral Drugs Market Size by Application (2017-2022) 7.3.2 Europe Influenza (Flu) Antiviral Drugs Market Size by Application (2023-2028) 7.3.3 Europe Influenza (Flu) Antiviral Drugs Market Share by Application (2017-2028) 7.4 Europe Influenza (Flu) Antiviral Drugs Market Size by Country 7.4.1 Europe Influenza (Flu) Antiviral Drugs Market Size by Country (2017-2022) 7.4.2 Europe Influenza (Flu) Antiviral Drugs Market Size by Country (2023-2028) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic Countries 8 Asia-Pacific 8.1 Asia-Pacific Influenza (Flu) Antiviral Drugs Market Size (2017-2028) 8.2 Asia-Pacific Influenza (Flu) Antiviral Drugs Market Size by Type 8.2.1 Asia-Pacific Influenza (Flu) Antiviral Drugs Market Size by Type (2017-2022) 8.2.2 Asia-Pacific Influenza (Flu) Antiviral Drugs Market Size by Type (2023-2028) 8.2.3 Asia-Pacific Influenza (Flu) Antiviral Drugs Market Share by Type (2017-2028) 8.3 Asia-Pacific Influenza (Flu) Antiviral Drugs Market Size by Application 8.3.1 Asia-Pacific Influenza (Flu) Antiviral Drugs Market Size by Application (2017-2022) 8.3.2 Asia-Pacific Influenza (Flu) Antiviral Drugs Market Size by Application (2023-2028) 8.3.3 Asia-Pacific Influenza (Flu) Antiviral Drugs Market Share by Application (2017-2028) 8.4 Asia-Pacific Influenza (Flu) Antiviral Drugs Market Size by Region 8.4.1 Asia-Pacific Influenza (Flu) Antiviral Drugs Market Size by Region (2017-2022) 8.4.2 Asia-Pacific Influenza (Flu) Antiviral Drugs Market Size by Region (2023-2028) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Influenza (Flu) Antiviral Drugs Market Size (2017-2028) 9.2 Latin America Influenza (Flu) Antiviral Drugs Market Size by Type 9.2.1 Latin America Influenza (Flu) Antiviral Drugs Market Size by Type (2017-2022) 9.2.2 Latin America Influenza (Flu) Antiviral Drugs Market Size by Type (2023-2028) 9.2.3 Latin America Influenza (Flu) Antiviral Drugs Market Share by Type (2017-2028) 9.3 Latin America Influenza (Flu) Antiviral Drugs Market Size by Application 9.3.1 Latin America Influenza (Flu) Antiviral Drugs Market Size by Application (2017-2022) 9.3.2 Latin America Influenza (Flu) Antiviral Drugs Market Size by Application (2023-2028) 9.3.3 Latin America Influenza (Flu) Antiviral Drugs Market Share by Application (2017-2028) 9.4 Latin America Influenza (Flu) Antiviral Drugs Market Size by Country 9.4.1 Latin America Influenza (Flu) Antiviral Drugs Market Size by Country (2017-2022) 9.4.2 Latin America Influenza (Flu) Antiviral Drugs Market Size by Country (2023-2028) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Influenza (Flu) Antiviral Drugs Market Size (2017-2028) 10.2 Middle East & Africa Influenza (Flu) Antiviral Drugs Market Size by Type 10.2.1 Middle East & Africa Influenza (Flu) Antiviral Drugs Market Size by Type (2017-2022) 10.2.2 Middle East & Africa Influenza (Flu) Antiviral Drugs Market Size by Type (2023-2028) 10.2.3 Middle East & Africa Influenza (Flu) Antiviral Drugs Market Share by Type (2017-2028) 10.3 Middle East & Africa Influenza (Flu) Antiviral Drugs Market Size by Application 10.3.1 Middle East & Africa Influenza (Flu) Antiviral Drugs Market Size by Application (2017-2022) 10.3.2 Middle East & Africa Influenza (Flu) Antiviral Drugs Market Size by Application (2023-2028) 10.3.3 Middle East & Africa Influenza (Flu) Antiviral Drugs Market Share by Application (2017-2028) 10.4 Middle East & Africa Influenza (Flu) Antiviral Drugs Market Size by Country 10.4.1 Middle East & Africa Influenza (Flu) Antiviral Drugs Market Size by Country (2017-2022) 10.4.2 Middle East & Africa Influenza (Flu) Antiviral Drugs Market Size by Country (2023-2028) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Pfizer 11.1.1 Pfizer Company Details 11.1.2 Pfizer Business Overview 11.1.3 Pfizer Influenza (Flu) Antiviral Drugs Introduction 11.1.4 Pfizer Revenue in Influenza (Flu) Antiviral Drugs Business (2017-2022) 11.1.5 Pfizer Recent Developments 11.2 Roche 11.2.1 Roche Company Details 11.2.2 Roche Business Overview 11.2.3 Roche Influenza (Flu) Antiviral Drugs Introduction 11.2.4 Roche Revenue in Influenza (Flu) Antiviral Drugs Business (2017-2022) 11.2.5 Roche Recent Developments 11.3 Sanofi 11.3.1 Sanofi Company Details 11.3.2 Sanofi Business Overview 11.3.3 Sanofi Influenza (Flu) Antiviral Drugs Introduction 11.3.4 Sanofi Revenue in Influenza (Flu) Antiviral Drugs Business (2017-2022) 11.3.5 Sanofi Recent Developments 11.4 Johnson & Johnson 11.4.1 Johnson & Johnson Company Details 11.4.2 Johnson & Johnson Business Overview 11.4.3 Johnson & Johnson Influenza (Flu) Antiviral Drugs Introduction 11.4.4 Johnson & Johnson Revenue in Influenza (Flu) Antiviral Drugs Business (2017-2022) 11.4.5 Johnson & Johnson Recent Developments 11.5 Merck & Co. (MSD) 11.5.1 Merck & Co. (MSD) Company Details 11.5.2 Merck & Co. (MSD) Business Overview 11.5.3 Merck & Co. (MSD) Influenza (Flu) Antiviral Drugs Introduction 11.5.4 Merck & Co. (MSD) Revenue in Influenza (Flu) Antiviral Drugs Business (2017-2022) 11.5.5 Merck & Co. (MSD) Recent Developments 11.6 Novartis 11.6.1 Novartis Company Details 11.6.2 Novartis Business Overview 11.6.3 Novartis Influenza (Flu) Antiviral Drugs Introduction 11.6.4 Novartis Revenue in Influenza (Flu) Antiviral Drugs Business (2017-2022) 11.6.5 Novartis Recent Developments 11.7 AbbVie 11.7.1 AbbVie Company Details 11.7.2 AbbVie Business Overview 11.7.3 AbbVie Influenza (Flu) Antiviral Drugs Introduction 11.7.4 AbbVie Revenue in Influenza (Flu) Antiviral Drugs Business (2017-2022) 11.7.5 AbbVie Recent Developments 11.8 Gilead Sciences 11.8.1 Gilead Sciences Company Details 11.8.2 Gilead Sciences Business Overview 11.8.3 Gilead Sciences Influenza (Flu) Antiviral Drugs Introduction 11.8.4 Gilead Sciences Revenue in Influenza (Flu) Antiviral Drugs Business (2017-2022) 11.8.5 Gilead Sciences Recent Developments 11.9 GlaxoSmithKline (GSK) 11.9.1 GlaxoSmithKline (GSK) Company Details 11.9.2 GlaxoSmithKline (GSK) Business Overview 11.9.3 GlaxoSmithKline (GSK) Influenza (Flu) Antiviral Drugs Introduction 11.9.4 GlaxoSmithKline (GSK) Revenue in Influenza (Flu) Antiviral Drugs Business (2017-2022) 11.9.5 GlaxoSmithKline (GSK) Recent Developments 11.10 Amgen 11.10.1 Amgen Company Details 11.10.2 Amgen Business Overview 11.10.3 Amgen Influenza (Flu) Antiviral Drugs Introduction 11.10.4 Amgen Revenue in Influenza (Flu) Antiviral Drugs Business (2017-2022) 11.10.5 Amgen Recent Developments 11.11 AstraZeneca 11.11.1 AstraZeneca Company Details 11.11.2 AstraZeneca Business Overview 11.11.3 AstraZeneca Influenza (Flu) Antiviral Drugs Introduction 11.11.4 AstraZeneca Revenue in Influenza (Flu) Antiviral Drugs Business (2017-2022) 11.11.5 AstraZeneca Recent Developments 11.12 Bristol-Myers Squibb 11.12.1 Bristol-Myers Squibb Company Details 11.12.2 Bristol-Myers Squibb Business Overview 11.12.3 Bristol-Myers Squibb Influenza (Flu) Antiviral Drugs Introduction 11.12.4 Bristol-Myers Squibb Revenue in Influenza (Flu) Antiviral Drugs Business (2017-2022) 11.12.5 Bristol-Myers Squibb Recent Developments 11.13 Eli Lilly 11.13.1 Eli Lilly Company Details 11.13.2 Eli Lilly Business Overview 11.13.3 Eli Lilly Influenza (Flu) Antiviral Drugs Introduction 11.13.4 Eli Lilly Revenue in Influenza (Flu) Antiviral Drugs Business (2017-2022) 11.13.5 Eli Lilly Recent Developments 11.14 Teva 11.14.1 Teva Company Details 11.14.2 Teva Business Overview 11.14.3 Teva Influenza (Flu) Antiviral Drugs Introduction 11.14.4 Teva Revenue in Influenza (Flu) Antiviral Drugs Business (2017-2022) 11.14.5 Teva Recent Developments 11.15 Bayer 11.15.1 Bayer Company Details 11.15.2 Bayer Business Overview 11.15.3 Bayer Influenza (Flu) Antiviral Drugs Introduction 11.15.4 Bayer Revenue in Influenza (Flu) Antiviral Drugs Business (2017-2022) 11.15.5 Bayer Recent Developments 11.16 Novo Nordisk 11.16.1 Novo Nordisk Company Details 11.16.2 Novo Nordisk Business Overview 11.16.3 Novo Nordisk Influenza (Flu) Antiviral Drugs Introduction 11.16.4 Novo Nordisk Revenue in Influenza (Flu) Antiviral Drugs Business (2017-2022) 11.16.5 Novo Nordisk Recent Developments 11.17 Allergan 11.17.1 Allergan Company Details 11.17.2 Allergan Business Overview 11.17.3 Allergan Influenza (Flu) Antiviral Drugs Introduction 11.17.4 Allergan Revenue in Influenza (Flu) Antiviral Drugs Business (2017-2022) 11.17.5 Allergan Recent Developments 11.18 Takeda 11.18.1 Takeda Company Details 11.18.2 Takeda Business Overview 11.18.3 Takeda Influenza (Flu) Antiviral Drugs Introduction 11.18.4 Takeda Revenue in Influenza (Flu) Antiviral Drugs Business (2017-2022) 11.18.5 Takeda Recent Developments 11.19 Boehringer Ingelheim 11.19.1 Boehringer Ingelheim Company Details 11.19.2 Boehringer Ingelheim Business Overview 11.19.3 Boehringer Ingelheim Influenza (Flu) Antiviral Drugs Introduction 11.19.4 Boehringer Ingelheim Revenue in Influenza (Flu) Antiviral Drugs Business (2017-2022) 11.19.5 Boehringer Ingelheim Recent Developments 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Author Details 13.3 Disclaimer

List of Tables Table 1. Global Influenza (Flu) Antiviral Drugs Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028 Table 2. Key Players of Penetration and Dehulling Inhibitors Table 3. Key Players of DNA Polymerase Inhibitors Table 4. Key Players of Reverse Transcriptase Inhibitors Table 5. Key Players of Protein Inhibitors Table 6. Key Players of Neuraminidase Inhibitors Table 7. Key Players of Broad-spectrum Antiviral Drugs Table 8. Global Influenza (Flu) Antiviral Drugs Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028 Table 9. Global Influenza (Flu) Antiviral Drugs Market Size by Region (US$ Million): 2017 VS 2021 VS 2028 Table 10. Global Influenza (Flu) Antiviral Drugs Market Size by Region (2017-2022) & (US$ Million) Table 11. Global Influenza (Flu) Antiviral Drugs Market Share by Region (2017-2022) Table 12. Global Influenza (Flu) Antiviral Drugs Forecasted Market Size by Region (2023-2028) & (US$ Million) Table 13. Global Influenza (Flu) Antiviral Drugs Market Share by Region (2023-2028) Table 14. Influenza (Flu) Antiviral Drugs Market Trends Table 15. Influenza (Flu) Antiviral Drugs Market Drivers Table 16. Influenza (Flu) Antiviral Drugs Market Challenges Table 17. Influenza (Flu) Antiviral Drugs Market Restraints Table 18. Global Influenza (Flu) Antiviral Drugs Revenue by Players (2017-2022) & (US$ Million) Table 19. Global Influenza (Flu) Antiviral Drugs Revenue Share by Players (2017-2022) Table 20. Global Top Influenza (Flu) Antiviral Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Influenza (Flu) Antiviral Drugs as of 2021) Table 21. Ranking of Global Top Influenza (Flu) Antiviral Drugs Companies by Revenue (US$ Million) in 2021 Table 22. Global 5 Largest Players Market Share by Influenza (Flu) Antiviral Drugs Revenue (CR5 and HHI) & (2017-2022) Table 23. Key Players Headquarters and Area Served Table 24. Key Players Influenza (Flu) Antiviral Drugs Product Solution and Service Table 25. Date of Enter into Influenza (Flu) Antiviral Drugs Market Table 26. Mergers & Acquisitions, Expansion Plans Table 27. Global Influenza (Flu) Antiviral Drugs Market Size by Type (2017-2022) & (US$ Million) Table 28. Global Influenza (Flu) Antiviral Drugs Revenue Market Share by Type (2017-2022) Table 29. Global Influenza (Flu) Antiviral Drugs Forecasted Market Size by Type (2023-2028) & (US$ Million) Table 30. Global Influenza (Flu) Antiviral Drugs Revenue Market Share by Type (2023-2028) Table 31. Global Influenza (Flu) Antiviral Drugs Market Size by Application (2017-2022) & (US$ Million) Table 32. Global Influenza (Flu) Antiviral Drugs Revenue Share by Application (2017-2022) Table 33. Global Influenza (Flu) Antiviral Drugs Forecasted Market Size by Application (2023-2028) & (US$ Million) Table 34. Global Influenza (Flu) Antiviral Drugs Revenue Share by Application (2023-2028) Table 35. North America Influenza (Flu) Antiviral Drugs Market Size by Type (2017-2022) & (US$ Million) Table 36. North America Influenza (Flu) Antiviral Drugs Market Size by Type (2023-2028) & (US$ Million) Table 37. North America Influenza (Flu) Antiviral Drugs Market Size by Application (2017-2022) & (US$ Million) Table 38. North America Influenza (Flu) Antiviral Drugs Market Size by Application (2023-2028) & (US$ Million) Table 39. North America Influenza (Flu) Antiviral Drugs Market Size by Country (2017-2022) & (US$ Million) Table 40. North America Influenza (Flu) Antiviral Drugs Market Size by Country (2023-2028) & (US$ Million) Table 41. Europe Influenza (Flu) Antiviral Drugs Market Size by Type (2017-2022) & (US$ Million) Table 42. Europe Influenza (Flu) Antiviral Drugs Market Size by Type (2023-2028) & (US$ Million) Table 43. Europe Influenza (Flu) Antiviral Drugs Market Size by Application (2017-2022) & (US$ Million) Table 44. Europe Influenza (Flu) Antiviral Drugs Market Size by Application (2023-2028) & (US$ Million) Table 45. Europe Influenza (Flu) Antiviral Drugs Market Size by Country (2017-2022) & (US$ Million) Table 46. Europe Influenza (Flu) Antiviral Drugs Market Size by Country (2023-2028) & (US$ Million) Table 47. Asia Pacific Influenza (Flu) Antiviral Drugs Market Size by Type (2017-2022) & (US$ Million) Table 48. Asia Pacific Influenza (Flu) Antiviral Drugs Market Size by Type (2023-2028) & (US$ Million) Table 49. Asia Pacific Influenza (Flu) Antiviral Drugs Market Size by Application (2017-2022) & (US$ Million) Table 50. Asia Pacific Influenza (Flu) Antiviral Drugs Market Size by Application (2023-2028) & (US$ Million) Table 51. Asia Pacific Influenza (Flu) Antiviral Drugs Market Size by Region (2017-2022) & (US$ Million) Table 52. Asia Pacific Influenza (Flu) Antiviral Drugs Market Size by Region (2023-2028) & (US$ Million) Table 53. Latin America Influenza (Flu) Antiviral Drugs Market Size by Type (2017-2022) & (US$ Million) Table 54. Latin America Influenza (Flu) Antiviral Drugs Market Size by Type (2023-2028) & (US$ Million) Table 55. Latin America Influenza (Flu) Antiviral Drugs Market Size by Application (2017-2022) & (US$ Million) Table 56. Latin America Influenza (Flu) Antiviral Drugs Market Size by Application (2023-2028) & (US$ Million) Table 57. Latin America Influenza (Flu) Antiviral Drugs Market Size by Country (2017-2022) & (US$ Million) Table 58. Latin America Influenza (Flu) Antiviral Drugs Market Size by Country (2023-2028) & (US$ Million) Table 59. Middle East and Africa Influenza (Flu) Antiviral Drugs Market Size by Type (2017-2022) & (US$ Million) Table 60. Middle East and Africa Influenza (Flu) Antiviral Drugs Market Size by Type (2023-2028) & (US$ Million) Table 61. Middle East and Africa Influenza (Flu) Antiviral Drugs Market Size by Application (2017-2022) & (US$ Million) Table 62. Middle East and Africa Influenza (Flu) Antiviral Drugs Market Size by Application (2023-2028) & (US$ Million) Table 63. Middle East and Africa Influenza (Flu) Antiviral Drugs Market Size by Country (2017-2022) & (US$ Million) Table 64. Middle East and Africa Influenza (Flu) Antiviral Drugs Market Size by Country (2023-2028) & (US$ Million) Table 65. Pfizer Company Details Table 66. Pfizer Business Overview Table 67. Pfizer Influenza (Flu) Antiviral Drugs Product Table 68. Pfizer Revenue in Influenza (Flu) Antiviral Drugs Business (2017-2022) & (US$ Million) Table 69. Pfizer Recent Developments Table 70. Roche Company Details Table 71. Roche Business Overview Table 72. Roche Influenza (Flu) Antiviral Drugs Product Table 73. Roche Revenue in Influenza (Flu) Antiviral Drugs Business (2017-2022) & (US$ Million) Table 74. Roche Recent Developments Table 75. Sanofi Company Details Table 76. Sanofi Business Overview Table 77. Sanofi Influenza (Flu) Antiviral Drugs Product Table 78. Sanofi Revenue in Influenza (Flu) Antiviral Drugs Business (2017-2022) & (US$ Million) Table 79. Sanofi Recent Developments Table 80. Johnson & Johnson Company Details Table 81. Johnson & Johnson Business Overview Table 82. Johnson & Johnson Influenza (Flu) Antiviral Drugs Product Table 83. Johnson & Johnson Revenue in Influenza (Flu) Antiviral Drugs Business (2017-2022) & (US$ Million) Table 84. Johnson & Johnson Recent Developments Table 85. Merck & Co. (MSD) Company Details Table 86. Merck & Co. (MSD) Business Overview Table 87. Merck & Co. (MSD) Influenza (Flu) Antiviral Drugs Product Table 88. Merck & Co. (MSD) Revenue in Influenza (Flu) Antiviral Drugs Business (2017-2022) & (US$ Million) Table 89. Merck & Co. (MSD) Recent Developments Table 90. Novartis Company Details Table 91. Novartis Business Overview Table 92. Novartis Influenza (Flu) Antiviral Drugs Product Table 93. Novartis Revenue in Influenza (Flu) Antiviral Drugs Business (2017-2022) & (US$ Million) Table 94. Novartis Recent Developments Table 95. AbbVie Company Details Table 96. AbbVie Business Overview Table 97. AbbVie Influenza (Flu) Antiviral Drugs Product Table 98. AbbVie Revenue in Influenza (Flu) Antiviral Drugs Business (2017-2022) & (US$ Million) Table 99. AbbVie Recent Developments Table 100. Gilead Sciences Company Details Table 101. Gilead Sciences Business Overview Table 102. Gilead Sciences Influenza (Flu) Antiviral Drugs Product Table 103. Gilead Sciences Revenue in Influenza (Flu) Antiviral Drugs Business (2017-2022) & (US$ Million) Table 104. Gilead Sciences Recent Developments Table 105. GlaxoSmithKline (GSK) Company Details Table 106. GlaxoSmithKline (GSK) Business Overview Table 107. GlaxoSmithKline (GSK) Influenza (Flu) Antiviral Drugs Product Table 108. GlaxoSmithKline (GSK) Revenue in Influenza (Flu) Antiviral Drugs Business (2017-2022) & (US$ Million) Table 109. GlaxoSmithKline (GSK) Recent Developments Table 110. Amgen Company Details Table 111. Amgen Business Overview Table 112. Amgen Influenza (Flu) Antiviral Drugs Product Table 113. Amgen Revenue in Influenza (Flu) Antiviral Drugs Business (2017-2022) & (US$ Million) Table 114. Amgen Recent Developments Table 115. AstraZeneca Company Details Table 116. AstraZeneca Business Overview Table 117. AstraZeneca Influenza (Flu) Antiviral Drugs Product Table 118. AstraZeneca Revenue in Influenza (Flu) Antiviral Drugs Business (2017-2022) & (US$ Million) Table 119. AstraZeneca Recent Developments Table 120. Bristol-Myers Squibb Company Details Table 121. Bristol-Myers Squibb Business Overview Table 122. Bristol-Myers Squibb Influenza (Flu) Antiviral Drugs Product Table 123. Bristol-Myers Squibb Revenue in Influenza (Flu) Antiviral Drugs Business (2017-2022) & (US$ Million) Table 124. Bristol-Myers Squibb Recent Developments Table 125. Eli Lilly Company Details Table 126. Eli Lilly Business Overview Table 127. Eli Lilly Influenza (Flu) Antiviral Drugs Product Table 128. Eli Lilly Revenue in Influenza (Flu) Antiviral Drugs Business (2017-2022) & (US$ Million) Table 129. Eli Lilly Recent Developments Table 130. Teva Company Details Table 131. Teva Business Overview Table 132. Teva Influenza (Flu) Antiviral Drugs Product Table 133. Teva Revenue in Influenza (Flu) Antiviral Drugs Business (2017-2022) & (US$ Million) Table 134. Teva Recent Developments Table 135. Bayer Company Details Table 136. Bayer Business Overview Table 137. Bayer Influenza (Flu) Antiviral Drugs Product Table 138. Bayer Revenue in Influenza (Flu) Antiviral Drugs Business (2017-2022) & (US$ Million) Table 139. Bayer Recent Developments Table 140. Novo Nordisk Company Details Table 141. Novo Nordisk Business Overview Table 142. Novo Nordisk Influenza (Flu) Antiviral Drugs Product Table 143. Novo Nordisk Revenue in Influenza (Flu) Antiviral Drugs Business (2017-2022) & (US$ Million) Table 144. Novo Nordisk Recent Developments Table 145. Allergan Company Details Table 146. Allergan Business Overview Table 147. Allergan Influenza (Flu) Antiviral Drugs Product Table 148. Allergan Revenue in Influenza (Flu) Antiviral Drugs Business (2017-2022) & (US$ Million) Table 149. Allergan Recent Developments Table 150. Takeda Company Details Table 151. Takeda Business Overview Table 152. Takeda Influenza (Flu) Antiviral Drugs Product Table 153. Takeda Revenue in Influenza (Flu) Antiviral Drugs Business (2017-2022) & (US$ Million) Table 154. Takeda Recent Developments Table 155. Boehringer Ingelheim Company Details Table 156. Boehringer Ingelheim Business Overview Table 157. Boehringer Ingelheim Influenza (Flu) Antiviral Drugs Product Table 158. Boehringer Ingelheim Revenue in Influenza (Flu) Antiviral Drugs Business (2017-2022) & (US$ Million) Table 159. Boehringer Ingelheim Recent Developments Table 160. Research Programs/Design for This Report Table 161. Key Data Information from Secondary Sources Table 162. Key Data Information from Primary Sources List of Figures Figure 1. Global Influenza (Flu) Antiviral Drugs Market Share by Type: 2021 VS 2028 Figure 2. Penetration and Dehulling Inhibitors Features Figure 3. DNA Polymerase Inhibitors Features Figure 4. Reverse Transcriptase Inhibitors Features Figure 5. Protein Inhibitors Features Figure 6. Neuraminidase Inhibitors Features Figure 7. Broad-spectrum Antiviral Drugs Features Figure 8. Global Influenza (Flu) Antiviral Drugs Market Share by Application: 2021 VS 2028 Figure 9. Hospital Case Studies Figure 10. Clinic Case Studies Figure 11. Household Case Studies Figure 12. Others Case Studies Figure 13. Influenza (Flu) Antiviral Drugs Report Years Considered Figure 14. Global Influenza (Flu) Antiviral Drugs Market Size (US$ Million), Year-over-Year: 2017-2028 Figure 15. Global Influenza (Flu) Antiviral Drugs Market Size, (US$ Million), 2017 VS 2021 VS 2028 Figure 16. Global Influenza (Flu) Antiviral Drugs Market Share by Region: 2021 VS 2028 Figure 17. Global Influenza (Flu) Antiviral Drugs Market Share by Players in 2021 Figure 18. Global Top Influenza (Flu) Antiviral Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Influenza (Flu) Antiviral Drugs as of 2021) Figure 19. The Top 10 and 5 Players Market Share by Influenza (Flu) Antiviral Drugs Revenue in 2021 Figure 20. North America Influenza (Flu) Antiviral Drugs Market Size YoY (2017-2028) & (US$ Million) Figure 21. North America Influenza (Flu) Antiviral Drugs Market Size Market Share by Type (2017-2028) Figure 22. North America Influenza (Flu) Antiviral Drugs Market Size Market Share by Application (2017-2028) Figure 23. North America Influenza (Flu) Antiviral Drugs Market Size Share by Country (2017-2028) Figure 24. United States Influenza (Flu) Antiviral Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 25. Canada Influenza (Flu) Antiviral Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 26. Europe Influenza (Flu) Antiviral Drugs Market Size YoY (2017-2028) & (US$ Million) Figure 27. Europe Influenza (Flu) Antiviral Drugs Market Size Market Share by Type (2017-2028) Figure 28. Europe Influenza (Flu) Antiviral Drugs Market Size Market Share by Application (2017-2028) Figure 29. Europe Influenza (Flu) Antiviral Drugs Market Size Share by Country (2017-2028) Figure 30. Germany Influenza (Flu) Antiviral Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 31. France Influenza (Flu) Antiviral Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 32. U.K. Influenza (Flu) Antiviral Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 33. Italy Influenza (Flu) Antiviral Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 34. Russia Influenza (Flu) Antiviral Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 35. Nordic Countries Influenza (Flu) Antiviral Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 36. Asia-Pacific Influenza (Flu) Antiviral Drugs Market Size YoY (2017-2028) & (US$ Million) Figure 37. Asia Pacific Influenza (Flu) Antiviral Drugs Market Size Market Share by Type (2017-2028) Figure 38. Asia Pacific Influenza (Flu) Antiviral Drugs Market Size Market Share by Application (2017-2028) Figure 39. Asia Pacific Influenza (Flu) Antiviral Drugs Market Size Share by Region (2017-2028) Figure 40. China Influenza (Flu) Antiviral Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 41. Japan Influenza (Flu) Antiviral Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 42. South Korea Influenza (Flu) Antiviral Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 43. Southeast Asia Influenza (Flu) Antiviral Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 44. India Influenza (Flu) Antiviral Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 45. Australia Influenza (Flu) Antiviral Drugs Market Size YoY Growth (2017-2028) & (US$ Million) List of Figures Figure 46. Latin America Influenza (Flu) Antiviral Drugs Market Size YoY (2017-2028) & (US$ Million) Figure 47. Latin America Influenza (Flu) Antiviral Drugs Market Size Market Share by Type (2017-2028) Figure 48. Latin America Influenza (Flu) Antiviral Drugs Market Size Market Share by Application (2017-2028) Figure 49. Latin America Influenza (Flu) Antiviral Drugs Market Size Share by Country (2017-2028) Figure 50. Mexico Influenza (Flu) Antiviral Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 51. Brazil Influenza (Flu) Antiviral Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 52. Middle East & Africa Influenza (Flu) Antiviral Drugs Market Size YoY (2017-2028) & (US$ Million) Figure 53. Middle East and Africa Influenza (Flu) Antiviral Drugs Market Size Market Share by Type (2017-2028) Figure 54. Middle East and Africa Influenza (Flu) Antiviral Drugs Market Size Market Share by Application (2017-2028) Figure 55. Middle East and Africa Influenza (Flu) Antiviral Drugs Market Size Share by Country (2017-2028) Figure 56. Turkey Influenza (Flu) Antiviral Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 57. Saudi Arabia Influenza (Flu) Antiviral Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 58. UAE Influenza (Flu) Antiviral Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 59. Pfizer Revenue Growth Rate in Influenza (Flu) Antiviral Drugs Business (2017-2022) Figure 60. Roche Revenue Growth Rate in Influenza (Flu) Antiviral Drugs Business (2017-2022) Figure 61. Sanofi Revenue Growth Rate in Influenza (Flu) Antiviral Drugs Business (2017-2022) Figure 62. Johnson & Johnson Revenue Growth Rate in Influenza (Flu) Antiviral Drugs Business (2017-2022) Figure 63. Merck & Co. (MSD) Revenue Growth Rate in Influenza (Flu) Antiviral Drugs Business (2017-2022) Figure 64. Novartis Revenue Growth Rate in Influenza (Flu) Antiviral Drugs Business (2017-2022) Figure 65. AbbVie Revenue Growth Rate in Influenza (Flu) Antiviral Drugs Business (2017-2022) Figure 66. Gilead Sciences Revenue Growth Rate in Influenza (Flu) Antiviral Drugs Business (2017-2022) Figure 67. GlaxoSmithKline (GSK) Revenue Growth Rate in Influenza (Flu) Antiviral Drugs Business (2017-2022) Figure 68. Amgen Revenue Growth Rate in Influenza (Flu) Antiviral Drugs Business (2017-2022) Figure 69. AstraZeneca Revenue Growth Rate in Influenza (Flu) Antiviral Drugs Business (2017-2022) Figure 70. Bristol-Myers Squibb Revenue Growth Rate in Influenza (Flu) Antiviral Drugs Business (2017-2022) Figure 71. Eli Lilly Revenue Growth Rate in Influenza (Flu) Antiviral Drugs Business (2017-2022) Figure 72. Teva Revenue Growth Rate in Influenza (Flu) Antiviral Drugs Business (2017-2022) Figure 73. Bayer Revenue Growth Rate in Influenza (Flu) Antiviral Drugs Business (2017-2022) Figure 74. Novo Nordisk Revenue Growth Rate in Influenza (Flu) Antiviral Drugs Business (2017-2022) Figure 75. Allergan Revenue Growth Rate in Influenza (Flu) Antiviral Drugs Business (2017-2022) Figure 76. Takeda Revenue Growth Rate in Influenza (Flu) Antiviral Drugs Business (2017-2022) Figure 77. Boehringer Ingelheim Revenue Growth Rate in Influenza (Flu) Antiviral Drugs Business (2017-2022) Figure 78. Bottom-up and Top-down Approaches for This Report Figure 79. Data Triangulation Figure 80. Key Executives Interviewed

Pfizer Roche Sanofi Johnson & Johnson Merck & Co. (MSD) Novartis AbbVie Gilead Sciences GlaxoSmithKline (GSK) Amgen AstraZeneca Bristol-Myers Squibb Eli Lilly Teva Bayer Novo Nordisk Allergan Takeda Boehringer Ingelheim